Albert Bourla
valid: Two independent sources agree, or a primary source states it: the record asserts this claim.asserted
- Valid from
- 2020-01-01
- Valid until
- still holds
- Published
- 2026-02-26
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-09 · its source page states the value and the date
- Confidence
- 0.95
Sources
“Albert Bourla, DVM, Ph.D. 64 Chairman of the Board since January 2020 and Chief Executive Officer since January 2019.”— what the page says, read 2026-11-09
Cite this claim
Plain text
AsOf. "Pfizer chair: Albert Bourla", as of 2020-01-01. Claim clm_97BD9CF6DBEF, https://asof.is/claim/clm_97BD9CF6DBEF, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/pfe-20251231.htm.
APA
AsOf. (2020). Pfizer chair: Albert Bourla (as of 2020-01-01) [Record clm_97BD9CF6DBEF]. Retrieved November 9, 2026, from https://asof.is/claim/clm_97BD9CF6DBEF (source: https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/pfe-20251231.htm)
BibTeX
@misc{asof_clm_97BD9CF6DBEF,
author = {AsOf},
title = {Pfizer chair: Albert Bourla},
year = {2020},
howpublished = {\url{https://asof.is/claim/clm_97BD9CF6DBEF}},
note = {Claim clm\_97BD9CF6DBEF, as of 2020-01-01; source: https://www.sec.gov/Archives/edgar/data/78003/000007800326000026/pfe-20251231.htm},
urldate = {2026-11-09}
}On the record
/claim/clm_97BD9CF6DBEF.md/v1/claims/clm_97BD9CF6DBEFsubmit a correction